Cancer Research AACR Conference on Molecular Diagnostics - 2008  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gu, J.
Right arrow Articles by Yuan, Z.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gu, J.
Right arrow Articles by Yuan, Z.-M.
[Cancer Research 61, 6703-6707, September 15, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

Subcellular Distribution of p53 and p73 Are Differentially Regulated by MDM21

Jijie Gu2, Linghu Nie2, Hidehiko Kawai and Zhi-Min Yuan3

Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115

The binding of MDM2 targets p53, but not p73, for degradation, whereas it suppresses the transactivation function of both proteins. MDM2 also mediates p53 nuclear export, but its role in the regulation of p73 distribution is unknown at the present time. We show here that, in sharp contrast to p53, MDM2 induces p73 to form nuclear aggregates that colocalize with MDM2 but are distinct from the promyelocytic leukemia dots. The MDM2 ring-domain that is necessary for mediating p53 nuclear export is not required for the induction of the p73 nuclear aggregates. Using a domain-swapping approach, we demonstrate that the inability of p73 to nuclear-export is attributable to its nonfunctional nuclear-export sequence.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
R. Malaguarnera, V. Vella, G. Pandini, M. Sanfilippo, V. Pezzino, R. Vigneri, and F. Frasca
TAp73{alpha} Increases p53 Tumor Suppressor Activity in Thyroid Cancer Cells via the Inhibition of Mdm2-Mediated Degradation
Mol. Cancer Res., January 1, 2008; 6(1): 64 - 77.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. R. Watson, A. Blanch, D. C. C. Lin, M. Ohh, and M. S. Irwin
Mdm2-mediated NEDD8 Modification of TAp73 Regulates Its Transactivation Function
J. Biol. Chem., November 10, 2006; 281(45): 34096 - 34103.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Brady, N. Vlatkovic, and M. T. Boyd
Regulation of p53 and MDM2 Activity by MTBP
Mol. Cell. Biol., January 15, 2005; 25(2): 545 - 553.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Liu, S. Nozell, H. Xiao, and X. Chen
{Delta}Np73{beta} Is Active in Transactivation and Growth Suppression
Mol. Cell. Biol., January 15, 2004; 24(2): 487 - 501.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. K. C. Tsai and Z.-M. Yuan
c-Abl Stabilizes p73 by a Phosphorylation-augmented Interaction
Cancer Res., June 15, 2003; 63(12): 3418 - 3424.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Inoue, J. Stuart, R. Leno, and C. G. Maki
Nuclear Import and Export Signals in Control of the p53-related Protein p73
J. Biol. Chem., April 19, 2002; 277(17): 15053 - 15060.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. A. E. Lohrum, D. B. Woods, R. L. Ludwig, E. Balint, and K. H. Vousden
C-Terminal Ubiquitination of p53 Contributes to Nuclear Export
Mol. Cell. Biol., December 15, 2001; 21(24): 8521 - 8532.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Gu, L. Nie, D. Wiederschain, and Z.-M. Yuan
Identification of p53 Sequence Elements That Are Required for MDM2-Mediated Nuclear Export
Mol. Cell. Biol., December 15, 2001; 21(24): 8533 - 8546.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Calabro, G. Mansueto, T. Parisi, M. Vivo, R. A. Calogero, and G. La Mantia
The Human MDM2 Oncoprotein Increases the Transcriptional Activity and the Protein Level of the p53 Homolog p63
J. Biol. Chem., January 18, 2002; 277(4): 2674 - 2681.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.